Wipro and Intel backed customer experience platform developer Lilt's $55m series C while Pfizer is buying corporate-backed respiratory virus therapeutic developer ReViral for up to $525m.
Funding
Lilt, a US-based provider of software which helps organisations tailor their online presences to a wider audience, secured $55m yesterday in a series C round featuring IT services Wipro and semiconductor technology producer Intel, which took part through corporate venturing subsidiaries Wipro Ventures and Intel Capital. Venture capital firm Four Rivers led the round, which included Sorenson Capital, Clear Ventures, Sequoia Capital, Redpoint Ventures and XSeed Capital.
Ceramics product manufacturer Corning added an undisclosed amount yesterday to a series…
